These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17009050)

  • 21. Radical cystectomy with an extended pelvic lymphadenectomy: rationale and results.
    Mills RD; Fleischmann A; Studer UE
    Surg Oncol Clin N Am; 2007 Jan; 16(1):233-45. PubMed ID: 17336246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [An analysis of upper urinary tract recurrence following radical cystectomy for bladder cancer].
    Sugi M; Fukui K; Yoshida K; Inui H; Kawakita S; Murota T; Kinoshita H; Matsuda T
    Hinyokika Kiyo; 2010 Feb; 56(2):87-90. PubMed ID: 20185992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncological and functional outcome of radical cystectomy in patients with bladder cancer and obstructive uropathy.
    Gupta NP; Kolla SB; Seth A; Hemal AK; Dogra PN; Kumar R
    J Urol; 2007 Oct; 178(4 Pt 1):1206-11; discussion 1211. PubMed ID: 17698145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Not Available].
    Albers P; Heidenreich A
    Aktuelle Urol; 2014 Nov; 45(6):490-8. PubMed ID: 25514780
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of pelvic lymph node dissection during radical cystectomy for bladder cancer.
    Brunocilla E; Pernetti R; Martorana G
    Anticancer Res; 2011 Jan; 31(1):271-5. PubMed ID: 21273609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors and clinical outcomes of patients with node-positive muscle-invasive bladder cancer.
    Bruins HM; Stein JP
    Expert Rev Anticancer Ther; 2008 Jul; 8(7):1091-101. PubMed ID: 18588454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
    J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variability in surgical quality in a phase III clinical trial of radical cystectomy in patients with organ-confined, node-negative urothelial carcinoma of the bladder.
    Mata DA; Groshen S; Von Rundstedt FC; Skinner DG; Stadler WM; Cote RJ; Stein JP; Lerner SP
    J Surg Oncol; 2015 Jun; 111(7):923-8. PubMed ID: 25873574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
    Stein JP; Cai J; Groshen S; Skinner DG
    J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of minimally invasive lymphadenectomy in bladder and prostate cancer surgery.
    Hakimi AA; Ghavamian R
    Urol Clin North Am; 2011 Nov; 38(4):407-18, v. PubMed ID: 22045172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of vascular invasion in patients with bladder cancer who underwent radical cystectomy.
    Harada K; Sakai I; Hara I; Eto H; Miyake H
    Int J Urol; 2005 Mar; 12(3):250-5. PubMed ID: 15828951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for recurrence following radical cystectomy for pathologic node negative bladder cancer.
    Hugen CM; Polcari AJ; Fitzgerald MP; Dauw C; Flanigan RC; Quek ML
    J Surg Oncol; 2010 Sep; 102(4):334-7. PubMed ID: 20607757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
    Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
    Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radical cystectomy without preoperative radiotherapy for invasive bladder carcinoma--a justified approach?
    Hohenfellner R; Jacobi GH
    Prog Clin Biol Res; 1984; 153():313-42. PubMed ID: 6473402
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of high-risk non-muscle invasive bladder cancer.
    Brausi M; Olaru V
    Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The evolving role of pelvic lymphadenectomy in the treatment of bladder cancer.
    Sanderson KM; Stein JP; Skinner DG
    Urol Oncol; 2004; 22(3):205-11; discussion 212-3. PubMed ID: 15271318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic and staging value of lymph node dissection in the treatment of invasive bladder cancer.
    Sanderson KM; Skinner D; Stein JP
    Nat Clin Pract Urol; 2006 Sep; 3(9):485-94. PubMed ID: 16964190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of pelvic lymphadenectomy in non-muscle invasive bladder cancer.
    Lin J; Deibert CM; Holder D; Benson MC; McKiernan JM
    Can J Urol; 2014 Feb; 21(1):7108-13. PubMed ID: 24529010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.